Science and Development Network
News, views and information about science, technology and the developing world
.jpg){kind=small}
.jpg){kind=spacer}
.jpg){kind=small}
A rising generics industry in developing nations is helping secure access to cheap drugs for the world's poor. But controversies over patent rules could divert investment from already neglected diseases.
(Photo credit: WHO/TDR/Crump)
Opinions and Analysis
Global treaty would improve access to health
A binding international convention would facilitate a move towards more equitable access to R&D in health, according to Suerie Moon and colleagues.
We need a global treaty on health research for the poor
It's time to move from debate to action with new mechanisms for funding research into diseases faced by developing countries.
Biomed Analysis: Why Africa must make its own drugs
22 March 2012
|
EN
Policy Briefs
Controlling insect pests with GM technology
Genetically modified insects provide a new method for controlling insect-borne diseases and agricultural insect pests.
8 July 2010
|
EN
Source: The Parliamentary Office of Science and Technology
Policies to tackle HIV/AIDS
Reducing the global burden of HIV/AIDS relies on increased funding, more research and targeted prevention strategies.
1 December 2009
|
EN
Source: Health Affairs
News and Features
Malaria vaccine candidate 'could be grown at home'
A novel malaria vaccine candidate could be grown at home, by cultivating algae in the backyard, say researchers.
24 May 2012
|
EN
'India's drug approvals put industry over people'
An expert panel will examine charges made by an Indian parliamentary committee of irregularities in approvals for new drugs.
11 May 2012
|
EN
Brazil to create network on neglected diseases
10 May 2012
|
ES
US should fund more late-stage health R&D, says report
4 May 2012
|
EN
